Discover
PLSE
Pulse Biosciences, Inc.
44.40
5 x 41.50
1 x 44.40
bid
ask
+
2.89
6.96%
2 @ 04:00 PM
43.52 -0.88 (1.98%)
| Ytd | 223.38% | |
| 1y | 198.39% |
41.09
day range
45.25
12.56
52 week range
45.90
| Open | 41.69 | Prev Close | 41.51 | Low | 41.09 | High | 45.25 | Mkt Cap | 3.07B |
| Vol | 0.00 | Avg Vol | 376.72K | EPS | -1.18 | P/E | -37.63 | Forward P/E | -36.72 |
| Beta | 1.58 | Short Ratio | 8.38 | Inst. Own | 12.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-04 | 50-d Avg | 29.24 | 200-d Avg | 21.01 | 1yr Est | 41.00 |
| Income Statement | |||
| Total Revenue | 434.00K | ||
| Revenues (USD) | 434.00K | ||
| Cost of Revenue | 273.00K | ||
| Gross Profit | 161.00K | ||
| Operating Expenses | 25.43M | ||
| Research and Development Expense | 16.98M | ||
| Selling, General and Administrative Expense | 8.46M | ||
| Operating Income | -25.27M | ||
| Net Income | -24.66M | ||
| Net Income Common Stock | -24.66M | ||
| Net Income Common Stock (USD) | -24.66M | ||
| Consolidated Income | -24.66M | ||
| Earnings per Basic Share | -0.36 | ||
| Earnings per Basic Share (USD) | -0.36 | ||
| Earnings per Diluted Share | -0.36 | ||
| Earning Before Interest & Taxes (EBIT) | -24.66M | ||
| Earning Before Interest & Taxes (USD) | -24.66M | ||
| Weighted Average Shares | 69.20M | ||
| Weighted Average Shares Diluted | 69.20M | ||
| Balance Sheet | |||
| Cash and Equivalents | 101.62M | ||
| Cash and Equivalents (USD) | 101.62M | ||
| Trade and Non-Trade Receivables | 122.00K | ||
| Current Assets | 105.70M | ||
| Property, Plant & Equipment Net | 6.45M | ||
| Total Assets | 115.56M | ||
| Debt Current | 1.69M | ||
| Total Debt | 6.77M | ||
| Current Liabilities | 10.98M | ||
| Debt Non-Current | 5.09M | ||
| Total Liabilities | 16.06M | ||
| Accumulated Retained Earnings (Deficit) | -506.52M | ||
| Shareholders Equity | 99.50M | ||
| Shareholders Equity (USD) | 99.50M | ||
| Assets Non-Current | 9.86M | ||
| Total Debt (USD) | 6.77M | ||
| Goodwill and Intangible Assets | 3.01M | ||
| Inventory | 236.00K | ||
| Liabilities Non-Current | 5.09M | ||
| Trade and Non-Trade Payables | 2.83M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 571.00K | ||
| Net Cash Flow from Financing | 52.10M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 33.30M | ||
| Capital Expenditure | -90.00K | ||
| Issuance (Purchase) of Equity Shares | 52.04M | ||
| Net Cash Flow from Investing | -90.00K | ||
| Net Cash Flow from Operations | -18.71M | ||
| Share Based Compensation | 4.97M | ||